Baker Bros. Advisors LP 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Baker Bros. Advisors LP | 146,561 4.990% | 63,505 (+76.46%) | Filing |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Baker Bros. Advisors LP | 83,056 5.300% | 83,056 (New Position) | Filing |